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Osteoporosis is a health concern characterized by reduced bone mineral density (BMD) and increased risk of
fragility fractures. Many studies have investigated the association between genetic variants and osteoporosis.
Polymorphism and allelic variations in the vitamin D receptor gene (VDR) have been found to be associated with
bone mineral density. However, many studies have not been able to find this association. Literature review was
conducted in several databases, including MEDLINE/Pubmed, Scopus, EMBASE, Ebsco, Science Citation Index
Expanded, Ovid, Google Scholar, Iran Medex, Magiran and Scientific Information Database (SID) for papers published
between 2000 and 2013 describing the association between Fok1 and Bsm1 polymorphisms of the VDR gene and
osteoporosis risk. The majority of the revealed papers were conducted on postmenopausal women. Also, more than
50% studies reported significant relation between Fok1, Bsm1 and osteoporosis. Larger and more rigorous analytical
studies with consideration of gene-gene and gene-environment interactions are needed to further dissect the
mechanisms by which VDR polymorphisms influence osteoporosis.
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The genetic variants of osteoporosis
Bone is a metabolically active tissue that experiences
continuous remodeling via two reciprocal processes, bone
formation and resorption. Respectively, osteoclasts, osteo-
blasts and osteocytes are responsible for bone resorp-
tion, formation and maintenance [1]. Osteoporosis is a
bone disease characterized by low bone density caused
by increased activity of osteoclasts and decreased bone
turnover [2,3].
The prevalence of osteoporosis varies between different
populations and ethnic groups [4-6] for example because
of the high degree of ethnic variety in China, different
studies show variety prevalence of osteoporosis [7-24].
Considering its high prevalence, the disease imposes a* Correspondence: Mahsaamoli@hotmail.com
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article, unless otherwise stated.heavy burden on the patients and families as well as the
healthcare system. In fact, the numbers of women with
osteoporotic fractures are higher than those who experi-
ence breast, ovary and uterus cancer [25-27].
Osteoporosis is a disease caused by the interaction of
genetic and environmental factors. According to many
studies, the contribution of genetic and environmental
factors is about 70% and 30% respectively. The environ-
mental factors can control gene expression and accord-
ingly, the process of the disease [28]. The study showed
that 60-80% feature of bone mass depends on genetics.
The Caucasians and Asians usually have lower bone
density values than Negros, Hispanics and Latino Amer-
icans [29]. In addition, studies have shown that female
offspring of osteoporotic women have lower bone dens-
ity in comparison with that of those with normal bone
density values [30]. Similarly, male offspring of men who
are diagnosed with idiopathic osteoporosis have lower
BMD in comparison with that of men with normal bone
density values [31]. Also, the study of female twins have
shown heritability of BMD to be 57% to 92% [32-35].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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man and experimental animals as well as candidate gene
studies and alterations in gene expression are being used
currently to identify the role of genes in this regard [36].
There are many relevant published studies of the gen-
etic susceptibility to osteoporosis. Genes can affect the
skeletal system in two ways. The first, control body up-
takes and intakes such as urinary calcium excretion to
modulate BMD, the second way is poor metabolism due
to genetic defects [37].
There calcium absorption pathways consists of trans_-
cellular and para_cellular. The trans_cellular pathway
closely depends on the action of calcitriol and the intes-
tinal vitamin D receptor. Transcellular transport occurs
primarily in the duodenum where the VDR (Vitamin D
receptor) is expressed in the highest concentration. So
the regulation of VDR gene is most important in high ef-
ficiency of calcium absorption [38,39].
Estrogens are known to play an important role in
regulating bone homeostasis and preventing postmeno-
pausal bone loss. They act through binding to two differ-
ent estrogen receptors (ERs), ERα and ERβ, which are
members of the nuclear receptor superfamily of ligand-
activated transcription factors. Both ER kinds are ex-
pressed in osteoblasts, osteoclasts, and bone marrow
stromal cells. And also ESRα has a prominent role in
regulating bone turnover and the maintenance of bone
mass [40,41].
Different studies have reported a list of effective genes
on osteoporosis; the most important of which are vita-
min D receptor gene(VDR), estrogen receptor alpha
(ESRα) ,interleukin -6 (IL-6), Collagen type I (COLIA1),
LDL receptor-related protein 5 (LRP5) [26,42,43].
Over the recent decades, genome-wide association
studies (GWAS) have contributed to the understanding
of gene structure in complex and chronic diseases such
as osteoporosis. Some of studies have indicated 62 sig-
nificant loci where control bone mineral density vari-
ation [27,44-47].
Candidate genes for BMD
Candidate gene studies have mainly focused on Vitamin
D receptor genes (VDR), type 1 Estrogen receptor genes
(ESR1) and type 1 Collagen (Coli1) [41,48-50]. In this
paper, the more important candidate genes, “VDR,” is
discussed.
Vitamin D receptor gene
Vitamin D receptor’s (VDR) genotypes have been associ-
ated with the development of several bone diseases as well
as multiple sclerosis (MS), osteoporosis, and vitamin D-
dependent rickets type II and other complex maladies [51].
The human gene encoding the VDR gene has been lo-
calized on chromosome 12q12-q14. Vitamin D receptors(VDRs) are members of the NR1I family, which also in-
cludes pregnane X (PXR) and constitutive androstane
(CAR) receptors, which form heterodimers with members
of the retinoid X receptor family [52]. VDR is expressed in
the intestine, thyroid and kidney and has a vital role
in calcium homeostasis. VDRs repress the expression
of 1-alpha-hydroxylase (the proximal activator of 1,25
(OH)2D3) and induce the expression of 1,25(OH)2D3
through inactivating the enzyme CYP24. Also, it has
recently been identified as an additional bile acid re-
ceptor alongside FXR with a protective role in gut
against the toxic and carcinogenic effects of these en-
dobiotics [53].
Gene ontology (GO) annotations related to this gene
include steroid hormone receptor activity and sequence-
specific DNA binding transcription factor activity. An
important paralog of this gene is NR4A3 [54].
There are more that 100 restriction endonuclease rec-
ognition sites in VDR gene and some of them are poly-
morphisms such as Fok1, Bsm1, Apa1 and …. .
Fok1 and Taq1 are located in exon 2 and 9 respect-
ively. And also, Bsm1 and Apa1 are located in intron 8.
Bsm1, Apa1 and Taq1 have been identified at the 3’ end
of the gene. The effects of VDR gene polymorphisms are
in connection with each other [55-57]. In many studies,
polymorphisms of VDR gene have been investigated. A
relationship between the VDR polymorphism and osteo-
porosis remain unclear requiring further in depth studies
[58,59].
A series of characterized VDR gene polymorphisms,
including Fok1, Bsm1, Taq1, and Apa1, have been exten-
sively studied with regard to their association with osteo-
porosis, but with vise versa results [41,60-63].
Significant associations of Fok1 polymorphism with
low BMD have been described in some studies, [64-66]
but not in others [67,68].
The Bsm1 restriction enzyme identifies a polymorphic
site at an intron at the 3′-end which is in linkage dis-
equilibrium with several other polymorphisms, including
Apa1, Taq1, and the variable-length poly(A) [69]. Al-
though functional data have been inconclusive for Bsm1,
several small studies evaluating Bsm1 have reported sig-
nificant associations with osteoporosis [70,71].
To clear the relationship between osteoporosis and




In this systematic review, the studies that had assessed
the association between VDR gene polymorphisms and
osteoporosis between 2000 and 2013 were included. In
all these studies the diagnosis of osteoporosis was per-
formed based on BMD measurement by Dual X-ray
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kinds of original studies such as cross-sectional, longitu-
dinal, and case controls were included. All review arti-
cles, Meta-analysis and systematic reviews after checking
references (to avoid missing any paper), were excluded.
Also, the articles performed on patients with secondary
osteoporosis as well as non-human studies (cell culture
or animal studies) and cellular-molecular discussions
were excluded. To avoid language bias non-English-
language publications were also included and Google-
Translator was used to extract these articles’ data.
Literature search and data extraction
The search strategy was based on electronic and hand
searching. Main key words in this systematic review were
Osteoporosis, Bone density, vitamin D receptor gene,820 of records identified through data base searching
38 of records after d
823 of records s
and ab







Figure 1 Flow diagram of the literature search.polymorphisms, Fok1 and Bsm1. We searched electronic
databases of biological and health sciences including
MEDLINE (pubmed), Scopus, EMBASE, Ebsco, Science
Citation Index Expanded, Ovid, Google Scholar, Iran
Medex, Magiran and Scientific Information Database
(SID). All national and international congresses about ge-
netic and osteoporosis like IOF and NOF congresses were
examined. And also expert’s curriculum vitae in this field
were checked for relevant studies. Subsequently, the sear-
ches were carried out and publications of interest were se-
lected, based on titles and abstracts. The full text of all
selected publications was assessed for relevance. If the full
texts of papers were not available, they were obtained
through correspondence with the authors. This was fol-
lowed by extracting the relevant data from the identified
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Table 1 Characteristics of studies included in the systematic review






1. Wynne, F [72] 2002 Ireland Irish PCR-RFLP Case-Control 511 381 130 Fok1
2. Van Pottelbergh [73] 2002 Belgium Belgium PCR-RFLP Case-Control 408 271 137 Fok1
3. Tarner [74] 2012 Turkey Turkish PCR-RFLP Case-Control 229 183 46 Fok1
4. Jakubowska [75] 2012 Netherlands Netherlands PCR-RFLP Case-Control 455 161 294 Fok1
5. Kanan [76] 2013 Jordan Jordanian PCR-RFLP Case-Control 210 120 90 Fok1
6. Zhang [77] 2006 Chinese Chinese PCR-RFLP Case-Control 92 26 66 Fok1
7. Kim, J. G [78] 2001 Korea Korean PCR-RFLP Cross-sectional 229 - - Fok1
8. Deng, H. W [79] 2002 USA Caucasian PCR-RFLP Cross-sectional 630 - - Fok1
9. Lau, E. M. C [9] 2002 Chinese Chinese PCR-RFLP Cross-sectional 684 - - Fok1
10. Chen,H . Y [80] 2002 Taiwan Taiwan PCR-RFLP Cross-sectional 163 - - Fok1
11. Strandberg, S. [81] 2003 Sweden Swedish PCR-RFLP Cross-sectional 88 - - Fok1
12. Rabon-stith,K. M [82] 2005 USA USA (Maryland) PCR-RFLP Cross-sectional 206 - - Fok1
13. Cusack, S. [83] 2006 Denmark Danish PCR-RFLP Cross-sectional 224 - - Fok1
14. Terpstra [84] 2006 Netherlands Netherlands PCR-RFLP Cross-sectional 120 - - Fok1
15. Lau, H. H. L [85] 2006 Chinese southern Chinese PCR-RFLP Cross-sectional 674 - - Fok1
16. Falchetti, A. [86] 2007 Italy Lampedusa (Italian) PCR-RFLP Cross-sectional 424 - - Fok1
17. Han, X. [87] 2009 Chinese Han PCR-RFLP Cross-sectional 100 - - Fok1
18. Hosseinnejad [88] 2009 IRAN IRAN PCR-RFLP Cross-sectional 205 - - Fok1
19. Hosseinnejad [89] 2009 IRAN IRAN PCR-RFLP Cross-sectional 312 - - Fok1
20. Ozaydin [90] 2010 Turkey Turkish PCR-RFLP Cross-sectional 88 - - Fok1
21. Galbav [91] 2010 Slovakia Slovak PCR-RFLP Cross-sectional 121 - - Fok1
22. Perez, A. [92] 2008 Argentina Cordoba PCR-RFLP Case-Control 176 108 68 Bsm1
23. Fontova, R. [93] 2000 Spain Spanish PCR-RFLP Case-Control 156 105 51 Bsm1
24. Uysal, A, R. [94] 2008 Turkey Turkish PCR-RFLP Case-Control 246 100 146 Bsm1
25. Eckstein [95] 2002 Israeli Jewish Israeli PCR-RFLP Case-Control 324 86 238 Bsm1
26. Borjas-Fajardo. L [96] 2003 Spain Spanish PCR-RFLP Case-Control 133 78 55 Bsm1
27. DurusuTanriover, M. [97] 2010 Turkey Turkish PCR-RFLP Case-Control 100 50 50 Bsm1
28. Chen, J. [98] 2003 Chinese Chinese PCR-RFLP Case-Control 61 40 21 Bsm1
29. Tamulaitien [99] 2012 Lithuania Lithuania PCR-RFLP Case-Control 73 28 45 Bsm1
30. Nelson [100] 2000 USA African-American PCR-RFLP Cross-sectional 43 - - Bsm1
31. Sowinska [101] 2000 Poland Polish PCR-RFLP Case-Control 88 40 48 Bsm1
32. Chen,H.Y [102] 2001 Chinese Chinese PCR-RFLP Cross-sectional 171 - - Bsm1
33. Pollak, R. D [103] 2001 Israeli Israelis PCR-RFLP Cross-sectional 634 - - Bsm1
34. Kubota, M [104] 2001 Japan Japanese PCR-RFLP Cross-sectional 126 - - Bsm1
35. Laaksonen, M. [105] 2002 Finland Finish PCR-RFLP Cross-sectional 93 - - Bsm1
36. van der Sluis, I. M. [106] 2003 Netherlands Caucasian PCR-RFLP Cross-sectional 148 - - Bsm1
37. Grundberg [107] 2003 Sweden Swedish PCR-RFLP Cross-sectional 343 - - Bsm1
38. Kammerer, C. M. [108] 2004 Mexico Mexican American PCR-RFLP Cross-sectional 471 - - Bsm1
39. Seremak-Mrozikiewicz, A
[132]
2004 Poland Polish PCR-RFLP Cross-sectional 34 - - Bsm1
40. Palomba, S. [110] 2005 Italy Italian PCR-RFLP Cross-sectional 1100 - - Bsm1
41. Dong, J. [111] 2006 Chinese Han PCR-RFLP Cross-sectional 90 - - Bsm1
42. Bernardes[112] 2005 Portugal Portuguese PCR-RFLP Cross-sectional 114 - - Bsm1
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Table 1 Characteristics of studies included in the systematic review (Continued)
43. Mitra, S. [113] 2006 India Indian PCR-RFLP Cross-sectional 246 - - Bsm1
44. Bezerra [114] 2008 Brazil Brazilian PCR-RFLP Cross-sectional 40 - - Bsm1
45. Musumeci [115] 2009 Italy Sicilian PCR-RFLP Cross-sectional 360 - - Bsm1
46. Stathopoulou, M. G. [116] 2011 Greece Greece PCR-RFLP Cross-sectional 578 - - Bsm1
47. Pouresmaeili [117] 2013 IRAN IRAN PCR-RFLP Cross-sectional 146 - - Bsm1
48. Horst -Sikorska, W. [118] 2007 Poland Polish PCR-RFLP Cross-sectional 279 - - Both
49. Gonzalez [119] 2013 Mexico Mexican-Mestizo TaqMan Case-Control 320 232 88 Both
50. Kanan, R. M. [120] 2008 Jordan Jordanian PCR-RFLP Case-Control 230 150 80 Both
51. Lisker, R [121] 2003 Mexico Mexican PCR-RFLP Case-Control 122 65 57 Both
52. Mansour, L. [122] 2010 Egypt Egyptian PCR-RFLP Case-Control 70 50 20 Both
53. Rogers [123] 2000 no indicated no indicated PCR-RFLP Cross-sectional 46 Both
54. Lorentzon [124] 2001 Sweden Caucasian PCR-RFLP Cross-sectional 99 - - Both
55. Zajíčková [125] 2002 Czech Czech PCR-RFLP Cross-sectional 114 - - Both
56. Vidal, C. [126] 2003 Malta Malta PCR-RFLP Cross-sectional 104 - - Both
57. Bandrés [127] 2005 Spain Caucasian PCR-RFLP Cross-sectional 177 - - Both
58. Ivanova, J. [128] 2006 Bulgaria Bulgarian PCR-RFLP Cross-sectional 219 - - Both
59. Macdonald, H. M [129] 2006 UK Scotland PCR-RFLP Cross-sectional 3100 - - Both
60. Yavuz [130] 2007 Turkey Turkish PCR-RFLP Case-Control 206 381 130 Both
61. Sanwalka [131] 2013 India Indian PCR-RFLP Case-Control 120 271 137 Both
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of disagreement, the third reviewer assessed the articles.
The following data were extracted from each published
article: name of the first author, publication year, the
number of case and control by gender, the number of
menopausal women, and the number of performed BMDs,
ethnic origin of the studied population, mean age, geno-
typing method (PCR-RFLP and TaqMan), Bone sites, and
the genotype frequency of the polymorphisms. The reli-
ability of data extraction forms was assessed by genetics
and endocrinology specialists. And the content validity
was assessed by 10 articles and was confirmed by 0.75
Cronbach’s Alpha. Methodological quality, the strength
and weaknesses of included studies were investigated
using a modified STROBE checklist.
Results and discussion
Baseline characteristics
A schematic of the literature search is shown in Figure 1.
According to the inclusion/exclusion criteria eligibility,
61 articles were identified regarding the associations be-
tween the Fok1 and Bsm1 polymorphisms of VDR gene
and osteoporosis risk. Among these studies, 21 studies
concerned the association of the Fok1 polymorphism
with osteoporosis [9,72-91], while 26 studies investigated
the association between Bsm1polymorphism and osteo-
porosis risk [92-117]. Also 14 articles evaluated both poly-
morphism associations with osteoporosis [118-131]. All ofthese 61 studies provided sufficient data to calculate the
possible relationship between the two polymorphisms of
the VDR gene and osteoporosis risk. The general charac-
teristics of the selected studies are summarized in Table 1.
In these studies, diverse groups of people were dis-
cussed. 36.5% of the studies studied postmenopausal
women. On the other hand, post-menopausal and pre-
menopausal woman were studied simultaneously in 22.2%
of the articles and 12.7% of them studied all groups.
According to the results, 96.8% of studies performed
the polymorphisms using PCR-RFLP “polymerase chain
reaction- restriction fragment length polymorphism”.
The other methods such as Taq-man were used to deter-
mine the association between Bsm1 and Fok1 polymor-
phisms and osteoporosis.
As mentioned above, the studies after year 2000 on
world were enrolled in this systematic review. Most arti-
cles were published in 2006 and after that the number of
papers showed a decline trend.
Based on articles, totally 17473 persons studied. 65.9%
of studies reported a significant relation between Bsm1
and osteoporosis risk. Likewise, 60.0% of studies re-
ported a significant relation between Fok1 and osteopor-
osis risk.
Also, the papers were categorized by gender and age.
The data indicated that most of the articles were done
on women and also on older ages. Most of studies were
examined post menopausal women.
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demonstrated that respectively china [9,77,85,87,98,102]
and Turkey [74,90,94,97,130] presented 6 and 5 studies
and identified as most active countries in such researches.
In conclusion, both gender and ethnicity are effective
factor on osteoporosis and bone mineral density.
As is evident, genetic variant has a tremendous roll
to adjust bone activities and therefore along with vita-
min D deficiency, has a large effect on osteoporosis
incidence and also osteoporotic fractures. In this sys-
tematic review, due to study the association between
low bone density and Bsm1 and Fok1 polymorphisms,
61 papers were studied and statistically analyzed. As a
main result, most of the studies were performed on
post-menopausal women i.e. the largest risk group to
their major content of research [132]. It seems that it
is necessary to evaluate the association of genetic variant
for lower age groups of both genders. Accordingly, genetic
testing can be used to prevent osteoporosis and low bone
density.
In more than 50% of studies a significant association
was found between the two polymorphisms (Fok1 and
Bsm1) and osteoporosis. Based on the articles, 65.9% of
studies reported a significant correlation between Bsm1
and osteoporosis risk. Likewise, 60.0% of studies re-
ported a significant correlation between Fok1 and osteo-
porosis risk. Most of the studies were performed in
developed countries but also, developing countries have
initiated this way.
An important and noticeable issue in this systematic
review is different results in different races [44,133]. Eth-
nicity and race, like gender, can influence the epidemi-
ology of osteoporosis and BMD. Some of studies indicate
that lowest BMD shown in white women and also,
bone mineral density is higher in African Americans
[134,135].
In more that 95% studies for assessing polymorphisms,
PCR-RFLP were used (Table 1). It is noteworthy; Taq-Man
is approximately novel methods which used [119].Conclusion
In summary, there is large ethnic and racial variability in
BMD levels and osteoporosis rates. Across all racial
groups and polymorphisms differences, women experi-
ence osteoporosis is more than the combined number of
women who experience breast cancer. Prevention efforts
should target all women, irrespective of their race and
ethnicity, especially if they have multiple risk factors.
And also, using novel and pioneer genetic techniques to
better assess and better quality can be useful.Competing interests
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